PT-141 10MG
$69.99 USD
Melanocortin receptor agonist (Bremelanotide) for MC3R/MC4R signaling research.
PT-141 (Bremelanotide) is a cyclic heptapeptide analogue of α-MSH derived from Melanotan-II via removal of the C-terminal amide. In preclinical research it has been studied as a non-selective melanocortin receptor agonist with primary activity at MC3R and MC4R, investigated for central nervous system melanocortin pathway signaling, neurogenic pathway modeling, and downstream hypothalamic response research.
Available sizes
Third party tested with a certificate of analysis. Sold strictly for laboratory research use only, not for human or veterinary use. 21+.